BioCentury | Sep 7, 2009
Company News

Pacgen management update

...Vancouver, B.C. Business: Infectious, Inflammation, Neurology Transitioned: Yiu Chung Lee to CEO, from CEO of XPhase Pharmaceuticals Inc....
BioCentury | Aug 24, 2009
Company News

Pacgen, XPhase Pharmaceuticals Inc. deal

...day before the deal closed (see BioCentury, May 11). Pacgen Biopharmaceuticals Corp. (TSX-V:PGA), Vancouver, B.C. XPhase Pharmaceuticals Inc....
BioCentury | May 11, 2009
Company News

Pacgen, XPhase Pharmaceuticals Inc. deal

...completed a Phase IIb trial to treat oral candidiasis. Pacgen Biopharmaceuticals Corp. (TSX-V:PGA), Vancouver, B.C. XPhase Pharmaceuticals Inc....
Items per page:
1 - 3 of 3
BioCentury | Sep 7, 2009
Company News

Pacgen management update

...Vancouver, B.C. Business: Infectious, Inflammation, Neurology Transitioned: Yiu Chung Lee to CEO, from CEO of XPhase Pharmaceuticals Inc....
BioCentury | Aug 24, 2009
Company News

Pacgen, XPhase Pharmaceuticals Inc. deal

...day before the deal closed (see BioCentury, May 11). Pacgen Biopharmaceuticals Corp. (TSX-V:PGA), Vancouver, B.C. XPhase Pharmaceuticals Inc....
BioCentury | May 11, 2009
Company News

Pacgen, XPhase Pharmaceuticals Inc. deal

...completed a Phase IIb trial to treat oral candidiasis. Pacgen Biopharmaceuticals Corp. (TSX-V:PGA), Vancouver, B.C. XPhase Pharmaceuticals Inc....
Items per page:
1 - 3 of 3